Revenue, 2020 (US$M)
$588.9
Forecast, 2028 (US$M)
$1,206.9
CAGR, 2021 - 2028
9.4%
Report Coverage
Russia

Russia covid-19 vaccine development tools market, 2020-2028 (US$M)

Russia

Russia covid-19 vaccine development tools market highlights

  • The Russia covid-19 vaccine development tools market generated a revenue of USD 588.9 million in 2020 and is expected to reach USD 1,206.9 million by 2028.
  • The Russia market is expected to grow at a CAGR of 9.4% from 2021 to 2028.
  • In terms of segment, laboratory technologies was the largest revenue generating technologies in 2020.
  • Online Technologies is the most lucrative technologies segment registering the fastest growth during the forecast period.


Covid-19 vaccine development tools market data book summary

Market revenue in 2020USD 588.9 million
Market revenue in 2028USD 1,206.9 million
Growth rate9.4% (CAGR from 2020 to 2028)
Largest segmentLaboratory technologies
Fastest growing segmentOnline Technologies
Historical data2020 - 2019
Base year2020
Forecast period2021 - 2028
Quantitative unitsRevenue in USD million
Market segmentationLaboratory Technologies, Online Technologies
Key market players worldwideThermo Fisher Scientific Inc, Pfizer Inc, Sartorius AG, Stemcell Holdings Inc Ordinary Shares, Illumina Inc, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, Merck KGaA, Qiagen NV, Shimadzu Corp, Eurofins Scientific SE, Charles River Laboratories International Inc, Takara Bio Inc, Olympus Corp, Avantor Inc, Aurora Innovation Inc Class A, Standard BioTools Inc, Celerion, Cole-Parmer, Hartford Schroders International Stk I, Revvity Inc, Fluidigm Corporation, Polyplus-transfection, Hamilton Lane Inc Class A


Other key industry trends

  • In terms of revenue, Russia accounted for 3.7% of the global covid-19 vaccine development tools market in 2020.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
  • In Europe, Germany covid-19 vaccine development tools market is projected to lead the regional market in terms of revenue in 2028.
  • Spain is the fastest growing regional market in Europe and is projected to reach USD 264.1 million by 2028.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

COVID-19 Vaccine Development Tools Market Companies

Name Profile # Employees HQ Website

Russia covid-19 vaccine development tools market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to covid-19 vaccine development tools market will help companies and investors design strategic landscapes.


Laboratory technologies was the largest segment with a revenue share of 95.35% in 2020. Horizon Databook has segmented the Russia covid-19 vaccine development tools market based on laboratory technologies, online technologies covering the revenue growth of each sub-segment from 2020 to 2028.


Russia was the first country to approve a COVID-19 vaccine in August 2020. The vaccine was developed by Gamely National Center of Epidemiology and Microbiology in Moscow and received approval from the President.

However, other regulators, such as the U.S. FDA and EMA, found insufficient information to approve the vaccination. In November 2021, the developer announced that Sputnik V was proven effective against the new Omicron and Delta variant.

The development of the vaccine was financially supported through the Russian Direct Investment Fund (RDIF). It is a sovereign fund with a capital of USD 10 billion under management and has investors from over 15 countries.

Reasons to subscribe to Russia covid-19 vaccine development tools market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Russia covid-19 vaccine development tools market databook

  • Our clientele includes a mix of covid-19 vaccine development tools market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Russia covid-19 vaccine development tools market , including forecasts for subscribers. This country databook contains high-level insights into Russia covid-19 vaccine development tools market from 2020 to 2028, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Russia covid-19 vaccine development tools market size, by technologies, 2020-2028 (US$M)

Russia COVID-19 Vaccine Development Tools Market Outlook Share, 2020 & 2028 (US$M)

Russia covid-19 vaccine development tools market size, by technologies, 2020-2028 (US$M)

Related regional statistics

No records

No related regions found.

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more